6 news items
NanoViricides Has Filed its Quarterly Report
NNVC
15 May 24
company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates
A Novel Broad-Spectrum Antiviral with Activity Against RSV
NNVC
14 May 24
that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
NNVC
10 May 24
") (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NNVC
8 May 24
") (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide®
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
NNVC
6 May 24
") (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials
8h6 dehh3c5
NNVC
30 Apr 24
") (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy
- Prev
- 1
- Next